Apoe in the bullseye of neurodegenerative diseases: impact of the apoe genotype in alzheimer’s disease pathology and brain diseases

HIGHLIGHTS

  • who: Rosalu00eda Fernu00e1ndez-Calle from the Department of Experimental Medical Science, Experimental Neuroinflammation Laboratory, Lund University, Lund, Sweden have published the research: APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimeru2019s disease pathology and brain diseases, in the Journal: (JOURNAL)

SUMMARY

    In the amyloidogenic pathway, APP is cleaved by β-secretase (also known as BACE-1), producing soluble APPβ (sAPPβ) and membrane-bound C-terminal 99 or 89 amino_acid fragments, also known as β-CTF. Cleavage of APP CTFs leads to the extracellular secretion of Aβ peptides mainly composed of . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?